Skip to main content
. 2022 Apr 6;63(3):393–401. doi: 10.1093/jrr/rrac012

Table 1.

Grading of adverse events analyzed in this study [1]

Acute toxicity (n = 21) Late toxicity (n = 12)
Treatment-Related Adverse Event Grade 1 or 2 n (%) Grade 3 n (%) Grade 4 n (%) Grade 1 or 2 n (%) Grade 3 n (%)
Conjunctivitis 7 (33) 0 0 2 (17) 0
Parotitis 14 (67) 0 0 1 (8) 0
Submandibular glanditis 7 (33) 0 0 0 0
Nausea 17 (81) 0 0 0 0
Vomiting 10 (48) 0 0 0 0
Loss of appetite 14 (67) 0 0 0 0
Fatigue 9 (43) 0 0 0 0
Hyperamylasemia 2 (10) 1 (5) 15 (71) 0 0
Hyperprolactinemia 12 (57) 0 0 0 0
Dry mouth 9 (43) 0 0 4 (33) 0
Dysgeusia 15 (71) 0 0 4 (33) -
Oral mucositis 12 (57) 1 (5) 0 2 (17) 0
Alopecia 20 (95) 0 0 12 (100) -
Dermatitis 8 (38) 1 (5) 0 1 (8) 0